Clinical Trials Logo

Cocaine Dependence, in Remission clinical trials

View clinical trials related to Cocaine Dependence, in Remission.

Filter by:
  • None
  • Page 1

NCT ID: NCT04884594 Recruiting - Clinical trials for Cocaine Dependence, in Remission

AAV8-hCocH for Cocaine Use Disorder

Start date: October 8, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test the safety of a novel gene viral vector treatment for adults with cocaine use disorder-sustained remission. This gene regulates an enzyme (cocaine hydrolase) that breaks down cocaine into inactive substances, thereby decreasing the pleasurable feeling this drug usually provides.

NCT ID: NCT03986762 Completed - Clinical trials for Cocaine-Related Disorders

Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid

CLAVMRPilot
Start date: March 12, 2019
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to determine how the study drug, clavulanic acid, affects glutamate in the brain using Magnetic Resonance (MR/MRI) scans. In this study, subjects will receive the study drug, clavulanic acid and undergo 4 MRI scans. This is being studied to determine the correct dosing of clavulanic acid, and to gather data so future studies can be done to find out if this drug is helpful in treating cocaine dependence. Currently, there is no available medication treatment for cocaine dependence.